rdf:type |
|
lifeskim:mentions |
umls-concept:C0007430,
umls-concept:C0008976,
umls-concept:C0019134,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0040861,
umls-concept:C0168273,
umls-concept:C0205178,
umls-concept:C0205281,
umls-concept:C0206460,
umls-concept:C0439609,
umls-concept:C0679199,
umls-concept:C0702240,
umls-concept:C0948089,
umls-concept:C1273870,
umls-concept:C1274040,
umls-concept:C1948041
|
pubmed:issue |
18
|
pubmed:dateCreated |
2008-5-2
|
pubmed:abstractText |
The aim of this study was to compare outcomes in patients receiving consistent unfractionated heparin (UFH)/enoxaparin (ENOX) therapy and in those switched at randomization to bivalirudin monotherapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1558-3597
|
pubmed:author |
pubmed-author:BertrandMichelM,
pubmed-author:ChewDerek PDP,
pubmed-author:FeitFrederickF,
pubmed-author:HoekstraJames WJW,
pubmed-author:LincoffA MichaelAM,
pubmed-author:MehranRoxanaR,
pubmed-author:MillerChadwick DCD,
pubmed-author:OhmanE MagnusEM,
pubmed-author:PocockStuartS,
pubmed-author:PollackCharles VCVJr,
pubmed-author:StoneGregg WGW,
pubmed-author:WareJamesJ,
pubmed-author:WhiteHarvey DHD
|
pubmed:issnType |
Electronic
|
pubmed:day |
6
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1734-41
|
pubmed:dateRevised |
2008-11-4
|
pubmed:meshHeading |
pubmed-meshheading:18452778-Acute Coronary Syndrome,
pubmed-meshheading:18452778-Adult,
pubmed-meshheading:18452778-Aged,
pubmed-meshheading:18452778-Aged, 80 and over,
pubmed-meshheading:18452778-Anticoagulants,
pubmed-meshheading:18452778-Enoxaparin,
pubmed-meshheading:18452778-Female,
pubmed-meshheading:18452778-Heart Conduction System,
pubmed-meshheading:18452778-Heparin,
pubmed-meshheading:18452778-Hirudins,
pubmed-meshheading:18452778-Humans,
pubmed-meshheading:18452778-Male,
pubmed-meshheading:18452778-Middle Aged,
pubmed-meshheading:18452778-Myocardial Ischemia,
pubmed-meshheading:18452778-Peptide Fragments,
pubmed-meshheading:18452778-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:18452778-Recombinant Proteins,
pubmed-meshheading:18452778-Risk Factors,
pubmed-meshheading:18452778-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
|
pubmed:affiliation |
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand. HarveyW@adhb.govt.nz
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|